COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome - Top-Institutions - MDSpire

COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

  • By

  • Maria Teresa Lupo-Stanghellini

  • Elisabetta Xue

  • Sara Mastaglio

  • Chiara Oltolini

  • Piera Angelillo

  • Carlo Messina

  • Simona Piemontese

  • Stefania Girlanda

  • Francesca Farina

  • Lorenzo Lazzari

  • Maria Pia Cicalese

  • Federico Erbella

  • Raffaella Greco

  • Massimo Locatelli

  • Raffaella Milani

  • Jacopo Peccatori

  • Consuelo Corti

  • Sarah Marktel

  • Andrea Assanelli

  • Fabio Ciceri

  • June 30, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    San Raffaele Scientific Institute
    San Raffaele Scientific Institute

    Milan, Lombardy

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, Washington

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #5

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

Original Source(s)

COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

  • by Maria Teresa Lupo-Stanghellini, Elisabetta Xue, Sara Mastaglio, Chiara Oltolini, Piera Angelillo, Carlo Messina, Simona Piemontese, Stefania Girlanda, Francesca Farina, Lorenzo Lazzari, Maria Pia Cicalese, Federico Erbella, Raffaella Greco, Massimo Locatelli, Raffaella Milani, Jacopo Peccatori, Consuelo Corti, Sarah Marktel, Andrea Assanelli, Fabio Ciceri

  • June 30, 2021

Related Content

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Deliberations on Government Spending Priorities: Listen to the People

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease